Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations

被引:10
作者
Messick, CR
Rodvold, KA
Pendland, SL
机构
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60612 USA
[2] Clin Res Pharm Coordinating Ctr, Dept Vet Affairs, Cooperat Studies Program, Albuquerque, NM 87106 USA
[3] Univ Illinois, Coll Med, Dept Pharm Practice, Chicago, IL 60612 USA
关键词
D O I
10.1093/jac/44.6.831
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study used a modified time-kill assay to compare the in-vitro activity of chloramphenicol and quinopristin/dalfopristin combined with vancomycin, ampicillin or gentamicin against multidrug-resistant Enterococcus faecium. The assay uses standardized time-kill methods with the following modifications: centrifugation of the test tubes at 1-2 h intervals, removal of supernatant and resuspension of bacteria in media containing antibiotic concentrations corresponding to simulated steady-state serum concentrations, None of the agents, alone or in combination, produced bactericidal or synergic activity. The modified time-kill assay more closely simulates in-vivo conditions and may provide a better qualitative assay to determine the interaction between antimicrobial agents and bacteria.
引用
收藏
页码:831 / 834
页数:4
相关论文
共 9 条
[1]   SIMULTANEOUS SIMULATION OF THE SERUM PROFILES OF 2 ANTIBIOTICS AND ANALYSIS OF THE COMBINED EFFECT AGAINST A CULTURE OF PSEUDOMONAS-AERUGINOSA [J].
BAUERNFEIND, A ;
JUNGWIRTH, R ;
PETERMULLER, C .
CHEMOTHERAPY, 1982, 28 (05) :334-340
[2]   CLINICAL PHARMACOLOGY OF AMPICILLIN AND HETACILLIN [J].
KIRBY, WMM ;
KIND, AC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1967, 145 (A2) :291-&
[3]   INVITRO COMPARISON OF AMPICILLIN-CHLORAMPHENICOL AND AMPICILLIN-CEFOTAXIME AGAINST 284 HAEMOPHILUS ISOLATES [J].
LAPOINTE, JR ;
LAVALLEE, C ;
MICHAUD, A ;
CHICOINE, L ;
JONCAS, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :594-597
[4]   In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant Enterococci [J].
Messick, CR ;
Pendland, SL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :203-205
[5]   PHARMACOKINETICS OF VANCOMYCIN [J].
MOELLERING, RC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :43-52
[6]  
*NAT COMM CLIN LAB, 1992, METH DET BACT ACT AN
[7]  
National Committee for Clinical Laboratory Standards, 1997, METH ANT SUSC TEST B
[8]  
WALLACE JF, 1967, J LAB CLIN MED, V70, P408
[9]  
[No title captured]